On the contrary, other studies have shown reduced AhR signaling in AML cells, with AhR promoting AML differentiation, suppressing leukemic burden, and modulating AML resistance to bromodomain inhibitors (17). The gene discussed is AHR; the disease is acute myeloid leukemia.